Moderator: John J. Dreyzehner, MD, MPH, FACOEM, Commissioner, Tennessee Department of Health, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board

CE Certified By: AMA,AAFP,ACPE,ANCC

In this interactive session, practicing clinicians — who have expertise in prescription drug monitoring programs (PDMPs) and clinical interventions — will discuss the ideal use of clinical decision tools that provide feedback and/or decision support to improve medical decision-making. PDMP-based interventions to improve prescribing decisions for controlled medications are recognized as best practices and are being implemented nationwide. Interventions such as unsolicited reports, provider report cards and mandated use hold promise as mechanisms to improve patient safety, inform providers and decrease high-risk prescribing. Unfortunately, thus far, providers have not been part of the development or implementation of these interventions and outcome data evaluating the impact is sparse. The presenters will provide recommendations, as well as explore the outcomes that should be considered in order to evaluate the utility of these interventions so risk and reward can be examined.

UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Describe the characteristics of ideal interventions to change provider decisions.
- Identify barriers to using PDMP feedback tools (unsolicited reports and report cards) and mandated use in the clinical setting.
- Explain how to evaluate outcomes associated with PDMP provider interventions including unsolicited. reporting, provider report cards and mandated use.